ParvezMantryMDAGAF, FAASLD

Gastroenterology • Dallas, TX

Advanced Endoscopic Interventional, Hepatology & Liver Transplantation

Physician

Join to view full profile

Dr. Mantry is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Mantry's full profile

Already have an account?

Office
1411 N Beckley Ave
Pav Iii Ste#268
Dallas, TX 75203
Phone+1 214-947-4400

Fax+1 214-947-4404
Is this information wrong?

Education & Training

University of RochesterFellowship, Gastroenterology, 2000 - 2003
Westchester Medical CenterResidency, Internal Medicine, 1997 - 2000
L. Tilak Municipal Medical CollegeClass of 1995

Certifications & Licensure

TX State Medical License 2008 - 2025
FL State Medical License 2005 - 2011
NY State Medical License 2003 - 2008

Clinical Trials

Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease Start of enrollment: 2005 Jun 01
Withdrawn
Phase 1, Phase 2
Autoimmune Hepatitis Study Start of enrollment: 2006 Jan 01
Terminated
Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure Start of enrollment: 2013 Feb 01
Completed
Phase 3
Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy Start of enrollment: 2013 Apr 03
Terminated
Phase 4
Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection Start of enrollment: 2013 Jun 01
Unknown status
Phase 2
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22
Terminated
Phase 3
Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124 Start of enrollment: 2016 Jul 31
Withdrawn
Early Phase 1
TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer Start of enrollment: 2014 May 22
Completed
Not Applicable
Mindfulness and Shared Decision Making Start of enrollment: 2018 Aug 15
Completed
CM-101 in PSC Patients -The SPRING Study Start of enrollment: 2020 Oct 01
Active, not recruiting
Phase 2
Roles: Contact
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement Start of enrollment: 2023 May 12
Recruiting
Phase 2
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

2 citations
Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single center
Rucha M. Shah, Sarah Sheikh, Jimmy Shah, Elaina Vivian, Alejandro Mejia, Islam Shahin, Parvez S. Mantry> ;Journal of Gastrointestinal Oncology. 2021 Aug 1
2 citations
Mindfulness at Methodist-A Prospective Pilot Study of Mindfulness and Stress Resiliency Interventions in Patients at a Tertiary Care Medical Center.
Elaina Vivian, Hellen Oduor, Preeti Girisha, Parvez Mantry> ;International Journal of Environmental Research and Public Health. 2021 Apr 12
32 citations
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis
Catherine Frenette, Zeid Kayali, Edward Mena, Parvez S. Mantry, Kathryn J. Lucas, Guy W. Neff, Miguel Á. Rodríguez, Paul J. Thuluvath, Ethan M. Weinberg, Bal R. Bhanda...> ;Journal of Hepatology. 2021 Feb 1
1 citations
Morphological Characteristics of Biliary Strictures after Liver Transplantation Visualized Using SpyGlass™ Cholangioscopy.
Yathip M. Chokpapone, Anne R. Murray, Ashwini P. Mehta, Vichin C. Puri, Alejandro Mejia, Parvez S. Mantry> ;Case Reports in Hepatology. 2020 Aug 4
47 citations
Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study
Philip N. Newsome, Melissa Palmer, Bradley Freilich, Muhammad Y. Sheikh, Aasim Sheikh, Harry Sarles, Robert Herring, Parvez S. Mantry, Zeid Kayali, Tarek Hassanein, Ha...> ;Journal of Hepatology. 2020 Aug 1
14 citations
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma
Nicole E. Rich, Ju Dong Yang, Ponni V. Perumalswami, Naim Alkhouri, Whitney E. Jackson, Neehar D. Parikh, Neil Mehta, Reena Salgia, Andres Duarte-Rojo, Laura Kulik, Mi...> ;Clinical Gastroenterology and Hepatology. 2020 Apr 1
106 citations
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma.
Amit G. Singal, Nicole E. Rich, Neil Mehta, Andrea D. Branch, Anjana Pillai, Maarouf Hoteit, Michael L. Volk, Mobolaji Odewole, Steven Scaglione, Jennifer Guy, Adnan S...> ;Gastroenterology. 2019 Nov 1
1 citations
PRO: Patients With Decompensated Cirrhosis Listed for Liver Transplantation Should Be Treated Pretransplant.
Tete Ukpong, Parvez Mantry> ;Clinical Liver Disease. 2019 Jul 1
4 citations
A Cross-Sectional Study of Stress and the Perceived Style of Decision-Making in Clinicians and Patients With Cancer.
Elaina Vivian, Hellen Oduor, Laurie Lundberg, Allison Vo, Parvez S. Mantry> ;Health Services Research and Managerial Epidemiology. 2019 Jun 13
108 citations
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Gastroenterology. 2019 May 1
15 citations
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease.
Eric Lawitz, Edward Gane, Eric Cohen, John M. Vierling, Kosh Agarwal, Tarek Hassanein, Parvez S. Mantry, Paul J. Pockros, Michael B. Bennett, Nyingi Kemmer, Giuseppe M...> ;Kidney International Reports. 2019 Feb 1
130 citations
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonser...
Saumya Jayakumar, Michael S. Middleton, Eric Lawitz, Parvez S. Mantry, Stephen H. Caldwell, Hays Arnold, Anna Mae Diehl, Reem Ghalib, Magdy Elkhashab, Manal F. Abdelma...> ;Journal of Hepatology. 2019 Jan 1
8 citations
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trials
Edward Tam, Anne F Luetkemeyer, Parvez S. Mantry, Sanjaya K. Satapathy, Peter Ghali, Minhee Kang, Richard Haubrich, Xianlin Shen, Liyun Ni, Gregory Camus, Amanda Copan...> ;Liver International. 2018 Jun 1
128 citations
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection
Nancy Reau, Paul Y. Kwo, Susan Rhee, Robert S. Brown, Kosh Agarwal, Peter W Angus, Edward Gane, Jia-Horng Kao, Parvez S. Mantry, David Mutimer, K. Rajender Reddy, Tram...> ;Hepatology. 2018 Jul 25
384 citations
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba, Eric Lawitz, Parvez S. Mantry, Saumya Jayakumar, Stephen H. Caldwell, Hays Arnold, Anna Mae Diehl, C. Stephen Djedjos, Ling Han, Robert P. Myers, G. Mani...> ;Hepatology. 2018 Feb 1
84 citations
Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial.
Julie A. Thompson, Natasha Jones, Ali Al-Khafaji, Shahid M. Malik, David J. Reich, Santiago J Munoz, Ross MacNicholas, Tarek Hassanein, Lewis W. Teperman, Lance L. Ste...> ;Liver Transplantation. 2018 Mar 1
20 citations
Selective internal radiation therapy using yttrium-90 resin microspheres in patients with unresectable hepatocellular carcinoma: a retrospective study.
Parvez S. Mantry, Ashwini P. Mehta, Bahar Madani, Alejandro Mejia, Islam Shahin> ;Journal of Gastrointestinal Oncology. 2017 Oct 1
163 citations
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis
Tarik Asselah, Kris V. Kowdley, Neddie Zadeikis, Stanley Wang, Tarek Hassanein, Yves Horsmans, Massimo Colombo, Filipe Calinas, Humberto Aguilar, Victor de Lédinghen, ...> ;Clinical Gastroenterology and Hepatology. 2017 Sep 22
16 citations
Sorafenib use for recurrent hepatocellular cancer after resection or transplantation: Observations from a US regional analysis of the GIDEON registry
Robert C.G. Martin, Elizabeth H. Bruenderman, Allen Lee Cohn, Bilal Piperdi, Rebecca A. Miksad, Jean Francois H. Geschwind, Alec Goldenberg, Arun J. Sanyal, Ellen Zigm...> ;American Journal of Surgery. 2017 Apr 1
1 citations
Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study.
Stefan Zeuzem, Parvez S. Mantry, Vicente Soriano, Robert Buynak, Jean-François Dufour, Paul J. Pockros, David Wright, Peter W Angus, Maria Buti, Jerry O. Stern, Werner...> ;European Journal of Gastroenterology & Hepatology. 2016 Aug 1
208 citations
Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease
Paul J. Pockros, K. Rajender Reddy, Parvez S. Mantry, Eric Cohen, Michael J. Bennett, Mark S. Sulkowski, David E. Bernstein, Nancy S. Shulman, Deli Wang, Amit Khatri, ...> ;Gastroenterology. 2016 Jun 1
Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials.
Donald M. Jensen, Tarik Asselah, Douglas T. Dieterich, Graham R. Foster, Mark S. Sulkowski, Stefan Zeuzem, Parvez S. Mantry, Eric M. Yoshida, Christophe Moreno, Denis ...> ;Annals of Hepatology. 2016 May 1
29 citations
Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis
A.A. Modi, Hector E. Nazario, James F. Trotter, Manjushree Gautam, Jeffrey L. Weinstein, Parvez S. Mantry, Maisha Barnes, Adil Habib, Jean L. McAfee, Olga Teachenor, L...> ;Liver Transplantation. 2016 Mar 1
Open‐label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1‐infected patients who failed placebo plus peginterferon and ribavirin
Graham R. Foster, Peter Ferenci, Tarik Asselah, Parvez S. Mantry, Jean-François Dufour, M. Bourlière, Daniel M. Forton, M. V. Maevskaya, David Wright, Eric M. Yoshida,...> ;Journal of Viral Hepatitis. 2016 Mar 1
30 citations
Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry
Jean Francois H. Geschwind, Pierre M. Gholam, Alec Goldenberg, Parvez S. Mantry, Robert C.G. Martin, Bilal Piperdi, Ellen Zigmont, Joanne Imperial, Svetlana Babajanyan...> ;Liver Cancer. 2016 Feb 1
Join now to see all

Press Mentions

Remdesivir Offers Hope for Hospitalized COVID-19 PatientsMay 7th, 2020

Hospital Affiliations

Methodist Dallas Medical CenterDallas, Texas
CHRISTUS Mother Frances Hospital - TylerTyler, Texas